FDA Takes Advisory Committee Off Life Support, Adds Analgesics To Title
This article was originally published in The Pink Sheet Daily
Executive Summary
The Anesthetics and Life Support Drugs Advisory Committee discussed analgesics at 11 of 14 meetings during the past four years, anesthetics at three, and life support drugs at none.
You may also be interested in...
Opioid REMS Needs Legislation Mandating Physician Training For Full Implementation
Training would be required for DEA licensing as FDA goes with advisory committee opinion that it should not be voluntary.
Pediatric Researcher Expresses Frustration With FDA Delay On Ketamine Trial
K.J.S. "Sunny" Anand, director of critical care at Le Bonheur Children's Hospital, said he has been waiting two and a half years for the agency to clear an IND for the drug.
Opioid Abuse-Deterrence Labeling May Be A Long Way Off After Panel Rejects Validity Of Broad Claim
Labeling should be specific, such as a claim for injection-resistance, committee members tell FDA.